MedPath

HEMORRO-DOL SUP

HEMORRO-DOL SUP

Discontinued
DIN Number

00540919

Drug Class

Human

Market Date

Dec 31, 1981

Company
HC

produits francais labs inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00540919
AIG Number0803849001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
C05AD03 BENZOCAINE
Product Specifications
Dosage FormSuppository
Route of AdministrationRectal
AHFS Classification84:08.00
Health Canada Classification

ACTIVE INGREDIENTS (8)

BELLADONNAActive
Strength: 11.25 MG / SUP
Monograph: BELLADONNA
BENZOCAINEActive
Strength: 50 MG / SUP
Monograph: BENZOCAINE
BISMUTH SUBCARBONATE (OXYCARBONATE)Active
Strength: 86.4 MG / SUP
Monograph: BISMUTH SUBCARBONATE (OXYCARBONATE)
BISMUTH SUBNITRATEActive
Strength: 37.8 MG / SUP
Monograph: BISMUTH SUBNITRATE
BORIC ACIDActive
Strength: 226.7 MG / SUP
Monograph: BORIC ACID
EPHEDRINE SULFATEActive
Strength: 2.5 MG / SUP
Monograph: EPHEDRINE SULFATE
PERUVIAN BALSAMActive
Strength: 22.6 MG / SUP
Monograph: PERUVIAN BALSAM
ZINC OXIDEActive
Strength: 226.7 MG / SUP
Monograph: ZINC OXIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.